12 Bands of Christmas Fights Pediatric Cancer
An organization raises money for research to fight pediatric cancers:
"“12 Bands of Christmas” is an organization that's been raising money to fight pediatric cancer for more than a decade. 26 News is a proud sponsor of their annual concert Saturday night. Liz Hill shares the story of an Augusta family who lives were changed by the organization.
Kriston Chandler: "His diagnosis is T-Cell Lymphoblastic Lymphoma." Those are the three words that rocked the Chandler family's world. Kriston's youngest son, William, had been diagnosed with cancer at the age of 2.
“Just almost panic, disbelief, complete disbelief,” says Kriston when asked about hearing the news. “I think in the back of my mind I kept thinking, he's going to fine. This isn't happening." What started off as labored breathing, a slight cough and night sweats turned into every parent's worst nightmare. "
Read More: http://www2.wagt.com/news/2010/dec/17/2/more-music-12-bands-helps-fight-...
More Articles
More Articles
Amazon.com is pleased to have the Lymphoma Information Network in the family of Amazon.com associates. We've agreed to ship items...
The question ought to be what are myelodysplastic syndromes (MDS), since this is a group of similar blood and bone marrow diseases that...
Merkel Cell Carcinoma (MCC) is a very rare and aggressive skin cancer that usually develops when a person is in his or her 70s. It is...
At some point, the Seattle biotech company Cell Therapeutics Inc (CTI) should earn an entry in the Guinness Book of World Records for utter and...
Site Beginnings
This site was started as Lymphoma Resource Page(s) in 1994. The site was designed to collect lymphoma...
Three papers appearing in the journal Blood and pointing towards a regulator-suppressor pill could offer hope to blood cancer...
The US Food and Drug Administration (FDA) has granted a third so-called Breakthrough Therapy Designation for the investigational oral...
The US Food and Drug Administration today has approved an expanded use of Imbruvica (ibrutinib) in patients with...
The U.S. Food and Drug Administration has announced that it has granted "Breakthrough Therapy Designation" for the investigational agent...
According to a new study published in the Proceedings of the National Academy of Sciences, a team from the University of California, San...
Pharmacyclics has announced that the company has submitted a New Drug Application (NDA) to the US Food and Drug Administration (FDA) for...
New research suggests that frontline radioimmunotherapy...
Gilead Sciences has announced results of the company's Phase II study of its investigational compound idelalisib, an oral inhibitor of...
